Filing search / Kineta, Inc. / "African American"

8-K

EX-99.2

KANT Kineta, Inc.

12 Mar 24

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts

8:05am

%) Black or African American 0 (0) 1 (20) 1 (25) 0 (0) 0 (0) 0 (0) 0 (0) 2 (7) Other 0 (0) 2 (40) 0 (0) 0 (0) 0 (0) 0 (0) 1 (20) 3 (11) White 2 (100) 2

8-K

EX-99.1

KANT Kineta, Inc.

5 Jan 24

Regulation FD Disclosure

4:30pm

/Ethnicity N (%) White Black or African American Hispanic or Latino 11 (74) 2 (13) 2 (13) Age Mean (Range) Years 62 (47-77) Characteristic Statistic

8-K

EX-99.2

KANT Kineta, Inc.

6 Nov 23

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

8:30am

(%) White Black or African American Hispanic or Latino Other/Not specified 7 (64) 2 (18) 1 (9) 1 (9) Age Mean (Range) Years 60.8 (47-72

8-K

ka4bded27kp5x

30 Dec 20

Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics

4:44pm